
A survey of US veterans with non-muscle invasive bladder cancer identifies barriers to treatment access, care coordination challenges, and gaps in patient education.
Martin Schlumberger, MD, Institut Gustave Roussy, Villejuif Cedex, professor of oncology, University Paris-Sud, France, discusses the takeaway points for a community oncologist from the SELECT trial.
Martin Schlumberger, MD, Institut Gustave Roussy, Villejuif Cedex, professor of oncology, University Paris-Sud, France, discusses the takeaway points for a community oncologist from the SELECT trial.
Learn more about targeted agents and radioactive iodine resistance > >
about 12 years ago
Unmet Needs in the Treatment of Thyroid Cancerabout 12 years ago
Immunotherapy in Head and Neck Cancersabout 12 years ago
Molecular Markers Emerge in the Diagnosis of Thyroid Cancerabout 12 years ago
Update on Targeted Therapies in Head and Neck Cancersabout 12 years ago
Multidisciplinary Approach to Head and Neck Cancers May Improve Outcomes





